1 潘志明. 鸡白痢沙门氏菌耐药性的变化趋势[J]. 中国预防兽医学报, 1999,21:305~307. 2 Barlow R S, Fegan N, Gobius K S. Integron-containing bacteria in faeces of cattle from different production systems at slaughter[J]. J Appl Microbiol, 2009, 107: 540~545. 3 Bischoff K M, White D G, McDermott P F, et al. Characterization of chloramphenicol resistance in beta-hemolytic Escherichia coli associated with diarrhea in neonatal swine[J]. J Clin Microbiol, 2002, 40: 389~394. 4 Bryan A, Shapir N, Sadowsky M J. Frequency and distribution of tetracycline resistance genes in genetically diverse, nonselected, and nonclinical Escherichia coli strains isolated from diverse human and animal sources[J]. Appl Environ Microbiol, 2004, 70: 2503~2507. 5 Barton M D. Antibiotic use in animal feed and its impact on human health[J]. Nutr Res Rev, 2000, 13: 279~299. 6 Catry B, Laevens H, Devriese L A, et al. Antimicrobial resistance in livestock[J]. J Vet Pharmacol Ther, 2003, 26: 81~93. 7 Courvalin P. Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria[J]. Antimicrob Agents Chemother, 1994, 38: 1447~1451. 8 Chen B, Zheng W W, Yu Y, et al. Class 1 integrons, selected virulence genes, and antibiotic resistance in Escherichia coli isolates from the Minjiang river, Fujian province, China[J]. Appl Environ Microbiol, 2011, 77: 148~155. 9 Díaz-Mejía J J, Amábile-Cuevas C F, Rosas I, et al. An analysis of the evolutionary relationships of integron integrases, with emphasis on the prevalence of class 1 integrons in Escherichia coli isolates from clinical and environmental origins[J]. Microbiology, 2008, 154: 94~102. 10 Gootz T D, Martin B A. Characterization of high-level quinolone resistance in Campylobacter jejuni[J]. Antimicrob Agents Chemother,1991,35:840~845. 11 Levy S B. Active efflux, a common mechanism for biocide and antibiotic resistance[J]. Symp Ser Soc Appl Microbiol, 2002, 92: 65S~71S. 12 Levy S B, Fitzgerald G B, Macone A B. Changes in intestinal flora of farm personnel after introduction of tetracycline-supplemented feed on a farm[J]. N Engl J Med, 1976, 295: 583~588. 13 Matsuoka M, Inoue M, Nakajima Y, et al. New erm gene in Staphylococcus aureus clinical isolates[J]. Antimicrob Agents Chemother, 2002, 46: 211~215. 14 Piddock L J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria[J]. Clin Microbiol Rev, 2006, 19: 382~402. 15 Randall L P, Woodward M J. The multiple antibiotic resistance (mar) locus and its significance[J]. Res Vet Sci, 2002, 72: 87~93. 16 Saenz Y, Brinas L, Dominguez E, et al. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins[J]. Antimicrob Agents Chemother, 2004, 48: 3996~4001. 17 Smith D L, Harris A D, Johnson J A, et al. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria[J]. Proc Natl Acad Sci, 2002, 99: 6434~6439. 18 Tenover F C. Mechanisms of antimicrobial resistance in bacteria[J]. Am J Infect Control, 2006, 34: S3~S10. 19 Van den Bogaard A E, Stobberingh E E. Antibiotic use in animals: Impact on bacterial resistance and public health[J]. Drugs, 1999, 58: 589~607. 20 Walsh C. Molecular mechanisms that confer antibacterial drug resistance[J]. Nature, 2000, 406: 775~781. 21 Walsh C, Wright G. Introduction: Antibiotic resistance[J]. Chem Rev, 2005, 105: 391~394. 22 Wright G D. Bacterial resistance to antibiotics: enzymatic degradation and modification[J]. Adv Drug Deliv Rev, 2005, 57: 1451~1470. |